News

News 16.10.2026 Kuros Biosciences increases 2026 annual guidance The company reports 40% year-over-year increase in sales in the first nine months of 2026 Schlieren (Zurich), Switzerland, October 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial performance for the first nine months...

News 14.10.2026 ZURICH, Switzerland – October 14, 2026 – AL-S Pharma AG (“AL-S Pharma” or “the Company”), a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the appointment of Harry Welten as chief executive officer (CEO). Mr. Welten succeeds Michael...

News 14.10.2026 Securecell and Beckman Coulter Life Sciences are collaborating on the integration of the Vi-CELL BLU Cell Viability Analyzer with Securecell's Numera® 3 automated sampling platform, creating a more automated workflow for cell culture monitoring. The new integration will combine automated liquid sample transfer with digital connectivity to enable a more seamless...

News 13.10.2026 The Schlieren-based company, led by CEO and co-founder Estelle Clerc, won the Environmental Award at the 2026 Swiss Future Awards. B Lab Switzerland and the PETRAM Foundation present this award to recognize sustainable solutions that are revolutionizing their industries and markets. Cellx BioSolutions received the award for its bacterial separation technology,...

News 12.10.2026 Gene therapies are used to treat many different blood disorders. However, blood stem cells often fail to achieve their full potential after transplantation. UZH researchers have now explored an alternative signaling pathway that could provide a remedy. Blood stem cells are rare cells in the bone marrow that produce the blood...